GeneDx Holdings Corp. - 10-Q Filing
GeneDx Holdings Corp. reports Q3 2026 financial results including revenue, R&D expense, and concentration risks.
Tickers: $WGS
GeneDx Holdings Corp. reports Q3 2026 financial results including revenue, R&D expense, and concentration risks.
Tickers: $WGS